370
Views
9
CrossRef citations to date
0
Altmetric
Cardiovascular

Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China

, , , &
Pages 1789-1794 | Received 05 Jan 2017, Accepted 26 Jun 2017, Published online: 09 Aug 2017

References

  • Guo Y, Wang H, Tian Y, et al. Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke. Thromb Haemost 2016;115:184-92
  • Wu X, Zhu B, Fu L, et al. Prevalence, incidence, and mortality of stroke in the Chinese island populations: a systematic review. PLoS One 2013;8:e78629
  • Yuan HW, Wang CX, Zhang N. Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study. PLoS One 2012;7:e46906
  • National Center for Cardiovascular Diseases, China. Report on Cardiovascular Diseases in China (2015). Encyclopedia of China Publishing House, 2015
  • Liu L, Wang D, Wong L, et al. Stroke and stroke care in China. Huge burden, significant workload, and a national priority. Stroke 2011;42:3651-4
  • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991:22;983-8
  • Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005;36:1115-59
  • Steger C, Pratter A, Bregel MM, et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 2004;25:1734-40
  • Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe. Data from a multicenter multinational hospital–based registry (The European Community Stroke Project). Stroke 2001;32:392-8
  • Tu HC, Campbell BC, Christensen S, et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypo perfusion, infarct growth, and hemorrhagic transformation. Int J Stroke 2015;10:534-40
  • Diringer MN, Edwards DF, Mattson DT, et al. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 1999;30:724-8
  • Roberts CS, Gorelick PB, Ye X, et al. Additional stroke-related and non–stroke-related cardiovascular costs and hospitalizations in managed-care patients after ischemic stroke. Stroke 2009;40:1425-32
  • Fernandez RL, Silver LE, Gutnikov SA, et al. Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC). Value Health 2013;16:280-7
  • Wang G, Joo H, Tong X, et al. Hospital costs associated with atrial fibrillation for patients with ischemic stroke aged 18–64 years in the United States. Stroke 2015;46:1314-20
  • Sussman M, Menzin J, Lin I, et al. Impact of atrial fibrillation on stroke-related healthcare costs. J Am Heart Assoc 2013;2:e000479
  • Ali AN, Howe J, Abdel-Hafiz A. Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm. Pharmacoeconomics 2015;33:511-20
  • Ghatnekar O, Glader EL. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. Value Health 2008;11:862-8
  • Hu S, Zhan L, Liu B, et al. Economic burden of individual suffering from atrial fibrillation–related stroke in china. Value Health 2013;2:135-40
  • International Statistical Classification of Diseases and Related Health Problems 10th Revision, ICD-10. Available at: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf [Last accessed 15 April 2016]
  • Shetty S, Halpern R, McCollam PL. Cost of care for new versus recurrent acute coronary syndrome patients. J Med Econ 2008;11:81-99
  • Ying LI, Wu YF, Chen KP, et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci 2013;26:709-16
  • Zhu HF, Newcommon NN, Cooper ME, et al. Impact of a stroke unit on length of hospital stay and in-hospital case fatality. Stroke 2009;40:18-23
  • Caro JJ, Walle KM, Ishak KJ, et al. The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada. BMC Health Serv Res 2006;6:99
  • Hejazi SMA, Mazlan M, Abdullah SJF, et al. Cost of post-stroke outpatient care in Malaysia. Singapore Med J 2015;56:116-19
  • Huang YC, Hu CJ, Lee TH, et al. The impact factors on the cost and length of stay among acute ischemic stroke. J Stroke Cerebrovasc Dis 2013;22:e152-1528
  • Guo Y, Wang H, Tian Y, et al. Time trends of aspirin and warfarin use on stroke and bleeding events in Chinese patients with new-onset atrial fibrillation. Chest 2015;148:62-72
  • Wang C, Wang Y, Wang C, et al. Anticoagulation-related reduction of first-ever stroke severity in Chinese patients with atrial fibrillation. J Clin Neurosci 2014;21:1755-60
  • Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 2008;18:209-16
  • Oldgren J, Healey JS, Ezekowitz M, et al. Variations in etiology and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY AF registry. Circulation 2014;129:1568-76
  • Sun YH, Hu DY. Chinese subgroup analysis of the global anticoagulant registry in the FIELD GARFIELD registry in the patients with non-valvular atrial fibrillation. Chinese J Cardiol 2014;10:846-50
  • Wang YL, Wu D, Nguyen-Huynh MN, et al. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey. Clin Exp Pharmacol 2010;37:775-81
  • Hendriks JM, de Wit R, Crijns HJ, et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J 2012;33:2692-9
  • Stewart S, Ball J, Horowitz JD, et al. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet 2015;385:775-84

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.